Abstract:Purpose: The Adverse Outcome Pathway (AOP) framework, a systematic tool that can link available mechanistic data with phenotypic outcomes of relevance to regulatory decision-making, is being explored in areas related to radiation risk assessment. To examine the challenges including the use of AOPs to support the radiation protection community, an international horizon-style exercise was initiated through the Organisation for Economic Co-operation and Development Nuclear Energy Agency High-Level Group on Low Dose Research Radiation/Chemical AOP Joint Topical Group. The objective of the HSE was to facilitate the collection of ideas from a range of experts, to short-list a set of priority research questions that could, if answered, improve the description of the radiation dose-response relationship for low dose/dose-rate exposures, as well as reduce uncertainties in estimating the risk of developing adverse health outcomes following such exposures. Materials and methods: The HSE was guided by an international steering committee of radiation risk experts. In the first phase, research questions were solicited on areas that can be supported by the AOP framework, or challenges on the use of AOPs in radiation risk assessment. In the second phase, questions received were refined and sorted by the SC using a best-worst scaling method. During a virtual 3-day workshop, the list of questions was further narrowed. In the third phase, an international survey of the broader radiation protection community led to an orderly ranking of the top questions. Results: Of the 271 questions solicited, 254 were accepted and categorized into 9 themes. These were further refined to the top 25 prioritized questions. Among these, the higher ranked questions will be considered as 'important' to drive future initiatives in the low dose radiation protection community. These included questions on the ability of AOPs to delineate responses across different levels of biological organization, and how AOPs could be applied to address research questions on radiation quality, doses or dose-rates, exposure time patterns and deliveries, and uncertainties in low dose/dose-rate effects. A better understanding of these concepts is required to support the use of the AOP framework in radiation risk assessment. Conclusion: Through dissemination of these results and considerations on next steps, the JTG will address select priority questions to advance the development and use of AOPs in the radiation protection community. The major themes observed will be discussed in the context of their relevance to areas of research that support the system of radiation protection.

International expert group collaboration for developing an adverse outcome pathway for radiation induced leukemia

Radiation adverse outcome pathways (AOPs) are on the horizon: advancing radiation protection through an international Horizon-Style exercise

Adverse outcome pathways: opportunities, limitations and open questions

Radiation Adverse Outcome pathways (AOPs): examining priority questions from an international horizon-style exercise

AOP report: Development of an adverse outcome pathway for deposition of energy leading to abnormal vascular remodeling

Mapping Adverse Outcome Pathways for Kidney Injury as a Basis for the Development of Mechanism-Based Animal-Sparing Approaches to Assessment of Nephrotoxicity

The adverse outcome pathway concept: a pragmatic tool in toxicology

AOP Report: Development of an adverse outcome pathway for deposition of energy leading to bone loss

Development of an adverse outcome pathway network for nephrotoxicity

AOP report: Development of an adverse outcome pathway for deposition of energy leading to cataracts

The First Steps on AOPs' Concepts, Development, and Applications in Teratology

AOP Report: An Upstream Network for Reduced Androgen Signaling Leading to Altered Gene Expression of Androgen Receptor–Responsive Genes in Target Tissues

Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment

Harvesting the promise of AOPs: An assessment and recommendations

Putative adverse outcome pathways for silver nanoparticle toxicity on mammalian male reproductive system: a literature review

Integrating basic radiobiological science and epidemiological studies: why and how

Reactive oxygen species and aldehyde dehydrogenase 1A as prognosis and theragnostic biomarker in acute myeloid leukaemia patients

IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept

A toxicity pathway-oriented approach to develop adverse outcome pathway: AHR activation as a case study

Acute Promyelocytic Leukemia in the Real World: Understanding Outcome Differences and How We Can Improve Them

Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation